Be Ready to Expedite Treatment for Malignant Hyperthermia
February 2018
Hospitals are striving to meet expectations for treating malignant hyperthermia.
About one in 2,000 people are at risk for malignant hyperthermia from exposure to anesthetic gases (desflurane, etc) or succinylcholine.
These patients can have muscle rigidity, hyperthermia, tachycardia, or hypercapnia from uncontrolled calcium release in the muscle...which can lead to rhabdomyolysis, arrhythmias, acute kidney injury, and death.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote